Phase I study of 5-azacytidine and oxaliplatin in patients with advanced cancers relapsed or refractory to platinum compounds

被引：0
|
作者：
Tsimberidou, Apostolia M. [1 ]
Culotta, Kirk [1 ]
Wistuba, Ignacio [1 ]
Fu, Siqing [1 ]
Naing, Aung [1 ]
Falchook, Gerald [1 ]
Piha-Paul, Sarina [1 ]
Zinner, Ralph [1 ]
Rodriguez-Canales, Jaime [1 ]
He, Guangan [1 ]
Siddik, Zahid H. [1 ]
Jelinek, Jaroslav [2 ]
Chung, Woonbok [2 ]
Ye, Yang [1 ]
Said, Rabih [3 ]
Hess, Kenneth [1 ]
Stewart, David J. [4 ]
Kurzrock, Razelle [5 ]
Issa, Jean-Pierre [2 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA
[3] UT Hlth Sci Ctr, Houston, TX USA
[4] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[5] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-CT201
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT201
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A phase I study of nifurtimox in patients with relapsed/refractory neuroblastoma
    Sholler, G. Saulnier
    Ferguson, W.
    Laurent, B.
    Johnson, G.
    Heath, B.
    Bingham, P.
    Taka, A.
    Kamen, B.
    Homans, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] PHASE-I STUDY OF OXALIPLATIN IN PATIENTS WITH ADVANCED CANCER
    EXTRA, JM
    ESPIE, M
    CALVO, F
    FERME, C
    MIGNOT, L
    MARTY, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (04) : 299 - 303
  • [33] A phase I/II trial of combination of PKC412 and 5-azacytidine (AZA) for the treatment of patients with refractory or relapsed (R/R) acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
    Nazha, Aziz
    Kantarjian, Hagop
    Borthakur, Gautam
    Kadia, Tapan M.
    Faderl, Stefan
    Ravandi, Farhad
    Estrov, Zeev
    Jabbour, Elias
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Phase II study of 5-fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin (POF) in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma
    Lin, R.
    Fan, N.
    Chen, L.
    Liu, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] PHASE II STUDY OF 5-FLUOROURACIL/LEUCOVORIN IN COMBINATION WITH PACLITAXEL AND OXALIPLATIN (POF) IN PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED ADVANCED OESOPHAGEAL AND GASTRIC CARCINOMA
    Lin, R.
    Fan, N.
    Chen, L.
    Liu, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 259 - 259
  • [36] A phase I study of lenalidomide in combination with bevacizumab, sorafenib, temsirolimus, or 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in patients with advanced cancers
    Subbiah, Ishwaria M.
    Kurzrock, Razelle
    Naing, Aung
    Piha-Paul, Sarina
    Falchook, Gerald S.
    Hong, David S.
    Wheler, Jennifer J.
    Fu, Siqing
    Laday, Shell
    Tsimberidou, Apostolia M.
    CANCER RESEARCH, 2012, 72
  • [37] Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
    Muhammad R. Khawaja
    Alpa M. Nick
    Vinu Madhusudanannair
    Siqing Fu
    David Hong
    Lacey M. McQuinn
    Chaan S. Ng
    Sarina A. Piha-Paul
    Filip Janku
    Vivek Subbiah
    Apostolia Tsimberidou
    Daniel Karp
    Funda Meric-Bernstam
    Karen H. Lu
    Aung Naing
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 973 - 977
  • [38] Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
    Khawaja, Muhammad R.
    Nick, Alpa M.
    Madhusudanannair, Vinu
    Fu, Siqing
    Hong, David
    McQuinn, Lacey M.
    Ng, Chaan S.
    Piha-Paul, Sarina A.
    Janku, Filip
    Subbiah, Vivek
    Tsimberidou, Apostolia
    Karp, Daniel
    Meric-Bernstam, Funda
    Lu, Karen H.
    Naing, Aung
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (05) : 973 - 977
  • [39] A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors
    Mascarenhas, Leo
    Malogolowkin, Marcio
    Armenian, Saro H.
    Sposto, Richard
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2013, 60 (07) : 1103 - 1107
  • [40] AMSACRINE ALONE OR IN COMBINATION WITH 5-AZACYTIDINE AND ETOPOSIDE IN REFRACTORY OR RELAPSED ACUTE NON LYMPHOBLASTIC-LEUKEMIA (ANLL)
    CARELLA, AM
    SANTINI, G
    MARTINENGO, M
    NATI, S
    GIORDANO, D
    CONGIU, A
    CERRI, R
    DAMASIO, E
    RISSO, M
    ROSSI, E
    MARMONT, AM
    HAEMATOLOGICA, 1985, 70 (01) : 39 - 43
12345